These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21521850)

  • 1. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
    Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
    JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.
    Morikawa T; Kuchiba A; Lochhead P; Nishihara R; Yamauchi M; Imamura Y; Liao X; Qian ZR; Ng K; Chan AT; Meyerhardt JA; Giovannucci E; Fuchs CS; Ogino S
    Cancer Res; 2013 Mar; 73(5):1600-10. PubMed ID: 23442321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
    Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
    Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.
    Morikawa T; Kuchiba A; Liao X; Imamura Y; Yamauchi M; Qian ZR; Nishihara R; Sato K; Meyerhardt JA; Fuchs CS; Ogino S
    Int J Cancer; 2012 Sep; 131(5):1169-78. PubMed ID: 22038927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.
    Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR
    Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
    Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
    Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
    Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
    Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
    Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of p27 localization in colon cancer, body mass index, and patient survival.
    Ogino S; Shima K; Nosho K; Irahara N; Baba Y; Wolpin BM; Giovannucci EL; Meyerhardt JA; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1849-58. PubMed ID: 19505918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
    Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
    Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
    PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
    Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.
    Hanyuda A; Kim SA; Martinez-Fernandez A; Qian ZR; Yamauchi M; Nishihara R; Morikawa T; Liao X; Inamura K; Mima K; Cao Y; Zhang X; Wu K; Chan AT; Giovannucci EL; Meyerhardt JA; Fuchs CS; Shivdasani RA; Ogino S
    Ann Surg Oncol; 2016 Mar; 23(3):908-17. PubMed ID: 26577117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.
    McCleary NJ; Sato K; Nishihara R; Inamura K; Morikawa T; Zhang X; Wu K; Yamauchi M; Kim SA; Sukawa Y; Mima K; Qian ZR; Fuchs CS; Ogino S; Meyerhardt JA
    Clin Cancer Res; 2016 Mar; 22(6):1489-98. PubMed ID: 26490308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of β-catenin association with obesity in African Americans with premalignant and malignant colorectal lesions.
    Shokrani B; Brim H; Hydari T; Afsari A; Lee E; Nouraie M; Sherif Z; Ashktorab H
    BMC Gastroenterol; 2020 Aug; 20(1):274. PubMed ID: 32811441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
    Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.
    Koh H; Hamada T; Song M; Liu L; Cao Y; Nowak JA; da Silva A; Twombly T; Morikawa T; Kim SA; Masugi Y; Kosumi K; Shi Y; Gu M; Li W; Du C; Chen Y; Li W; Liu H; Li C; Wu K; Nosho K; Inamura K; Hanyuda A; Zhang X; Giannakis M; Chan AT; Fuchs CS; Nishihara R; Meyerhardt JA; Ogino S
    JNCI Cancer Spectr; 2018 Oct; 2(4):pky058. PubMed ID: 31276098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Dehari R; Meyerhardt JA; Fuchs CS; Ogino S
    Neoplasia; 2007 Jul; 9(7):569-77. PubMed ID: 17710160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.